Auspex Pharmaceuticals Inc. (Nasdaq: ASPX) agreed to be acquired by Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) in a transaction valued at approximately $3.5 billion. Shares of Auspex leaped $29.58 to $100.49 while Teva stock edged up 90 cents to $62.88.